Suphamai Bunnapradist, MD, MS

Articles by Suphamai Bunnapradist, MD, MS
Phase 3 TRANSCEND Study Will Evaluate Use of Felzartamab for AMR
Suphamai Bunnapradist, MD, MSKidney Transplantation | April 1, 2025
Suphamai Bunnapradist discussed the phase 3 TRANSCEND study of felzartamab to treat late AMR after kidney transplantation.
View More
dd-cfDNA Test as an Indicator of Transplant Rejection
Suphamai Bunnapradist, MD, MSKidney Transplantation | June 6, 2024
A study by Suphamai Bunnapradist and others found that dd-cfDNA is an early indicator of kidney transplant rejection.
View More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |